Loading...
•
Mar 31, 2020
Merit Medical Q1 2020 Earnings Report
Merit Medical's Q1 2020 earnings were reported, showing a slight revenue increase but a GAAP loss per share, while non-GAAP EPS improved slightly. The company withdrew its full-year 2020 guidance due to the COVID-19 pandemic.
Key Takeaways
Merit Medical reported a 2.2% increase in worldwide revenue for Q1 2020, reaching $243.5 million. However, the company experienced a GAAP loss per share of $(0.06), compared to a GAAP EPS of $0.11 in Q1 2019. Non-GAAP EPS was $0.38, slightly up from $0.37 in Q1 2019. Due to the uncertainty caused by the COVID-19 pandemic, Merit Medical has withdrawn its FY 2020 guidance.
Worldwide revenue increased by 2.2% to $243.5 million compared to Q1 2019.
Core revenue on a constant currency basis increased by 3.0% over Q1 2019.
GAAP loss per share was $(0.06), compared to GAAP EPS of $0.11 in Q1 2019.
Non-GAAP EPS was $0.38, compared to $0.37 in Q1 2019.
Forward Guidance
Due to the general uncertainty related to the coronavirus pandemic and corresponding economic downturn, Merit’s management has concluded that it cannot issue financial guidance for the remainder of 2020. As such, Merit’s previously issued 2020 guidance is withdrawn until further notice.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...